Compare Etsy Inc (ETSY) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Etsy Inc vs Tango Therapeutics Inc. — how do they compare? Etsy Inc trades at $82.12 (market cap $7.61B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.74B). The key difference: Etsy Inc is far larger — about 2× Tango Therapeutics Inc.'s market cap, and Etsy Inc is trading nearer its 52-week high, Tango Therapeutics Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Etsy Inc for 67 Days and Tango Therapeutics Inc. for 0 Days on average.
| ETSY | TNGX | |
|---|---|---|
Market Cap | $7.61B | $3.74B |
Volume | 3,831,386 | 3,438,781 |
Sector | Consumer Cyclical | Health |
52-Week High | $87.03 | $32.90 |
52-Week Low | $44.05 | $7.50 |
Typical Hold Time | 67 Days | 0 Days |
Enterprise Value | $9.56B | $2.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ETSY trades at $79.28, up 3.05% today, with a bullish technical signal and strong institutional interest. Recent earnings beats and a 71.4% gross margin highlight operational strength, though net income margin compressed to 5.65% in 2025. The stock is near its consensus price target of $85.94, with positive sentiment driven by AI initiatives and partnership renewals.
Outlook is cautiously optimistic given analyst support and growth initiatives, but risks include high debt-to-asset ratio (105.48% in 2025) and competitive e-commerce pressures. Upside hinges on AI-driven personalization boosting revenue, while margin pressure and macroeconomic headwinds pose challenges.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
